Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.

Journal of medical genetics - 1 Feb 2014

Bloss Cinnamon S, Schork Nicholas J, Topol Eric J

Abstract excerpt

BACKGROUND: Direct-to-consumer (DTC) genomic testing has generated controversy, however the actual impact of testing on consumer behaviour has been understudied, particularly for pharmacogenomic (PGx) testing. METHODS: We recruited a sample of adults who purchased a DTC genomic test and had previously received their genomic test results for complex disease risk. All participants additionally underwent PGx...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Counseling
Share to Genetic Predisposition to Disease
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Patient Participation

Share to Pharmacogenetics

Share to Practice Patterns, Physicians'

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 24343916
DOI: 10.1136/jmedgenet-2013-101909

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.PMID 24343916Read ↗

Impact of direct-to-consumer genomic testing at long term follow-up.Semantic proximity Read ↗

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Semantic proximity Read ↗

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.Semantic proximity Read ↗

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.Semantic proximity Read ↗

Sharing behavior and health care utilization following direct-to-consumer genetic testing: a systematic reviewSemantic proximity Read ↗

Sharing behavior and health care utilization following direct-to-consumer genetic testing: a systematic reviewSemantic proximity Read ↗

The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study.Semantic proximity Read ↗

Effect of Direct‐to‐Consumer Genetic Tests on Health Behaviour and Anxiety: A Survey of Consumers and Potential ConsumersSemantic proximity Read ↗

Effect of direct-to-consumer genomewide profiling to assess disease risk.Semantic proximity Read ↗

Direct-to-Consumer Personal Genome Testing and Cancer Risk PredictionSemantic proximity Read ↗

Direct-To-Consumer Genetic Testing: Where and How Does Genetic Counseling Fit?Semantic proximity Read ↗

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.